Cambridge Bioscience is pleased to announce that we have partnered with Bio X Cell, a leading provider of high-quality antibodies for in vivo pre-clinical research. This collaboration aims to enhance access to Bio X Cell’s ultra-pure, low endotoxin antibodies for researchers across the United Kingdom and Ireland.
With a strong reputation for delivering antibodies formulated without preservatives or stabilisers, Bio X Cell supports groundbreaking research in cancer, immunology, neuroscience, and more. The company manufactures its proprietary InVivoMAb™ and InVivoPlus™ antibodies in-house in the United States, ensuring rigorous quality control and consistent product availability.
Through this partnership, Cambridge Bioscience will distribute Bio X Cell’s extensive antibody portfolio, providing UK and Ireland researchers with reliable access to these specialised reagents. Additionally, Bio X Cell’s flexible antibody production and conjugation services will be more readily available to laboratories with unique research needs.
Find out more about Bio X Cell's products or contact our Bio X Cell specialists.